Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  PAREXEL International Corporation    PRXL

Delayed Quote. Delayed  - 09/23 10:00:00 pm
70.14 USD   +0.27%
09/20 PAREXEL INTERNA : Christian Dreger Joins PAREXEL as Senior Vice Pres..
09/19 PAREXEL INTERNA : Christian Dreger Joins PAREXEL as Senior Vice Pres..
09/16 INVESTOR LOSS A : Rosen Law Firm Announces Investigation of Securiti..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAREXEL International Corp
Provides clinical research and development services

PAREXEL International Corp. is a biopharmaceutical services company.

It provides clinical research, medical communications, consulting, commercialization and informatics, and technology services to pharmaceutical, biotechnology, and medical device industries.

The company operates through the following segments: Clinical Research Services, PAREXEL Consulting Services and PAREXEL Informatics.

The Clinical Research Services segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, date management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, pharmacovigilance, clinical pharmacology, and related medical affiairs, patient recruitment and investigator site services.

The PAREXEL Consulting Services segment provides technical expertise and advice in drug development, regulatory affairs, and good manufacturing practice compliance consulting.

The PAREXEL Informatics segment provides information technology solutions designed to improve client's product development processes.

PAREXEL International was founded by Josef H. von Rickenbach and Anne B. Sayigh in 1983 and is headquartered in Waltham, MA.

Number of employees : 18 600 persons.
Sales per Businesses
20152016Delta
USD (in Million)%USD (in Million)%
Clinical Research Services1,53565.8%1,62667% +5.9%
PAREXEL Informatics264.6711.3%277.9011.4% +5%
PAREXEL Consulting Services215.959.3%190.407.8% -11.83%
Sales per Regions
20152016Delta
USD (in Million)%USD (in Million)%
United States984.6842.2%908.9037.4% -7.7%
Europe, Middle East & Africa451.4619.4%568.1023.4% +25.84%
Asia/Pacific269.3011.5%296.7012.2% +10.18%
United Kingdom239.6510.3%251.0010.3% +4.74%
Americas70.903%69.602.9% -1.83%
Managers
NameAgeSinceTitle
Josef H. von Rickenbach, MBA611983Chairman & Chief Executive Officer
Mark A. Goldberg, MD551997President & Chief Operating Officer
Emma Reeve552014Chief Financial Officer, VP & Controller
Roland Andersson, PhD522014Senior Vice President-Clinical Research Services
Sy Pretorius MD, MBA--Chief Scientific Officer & Vice President
A. Dana Callow Jr., MBA641986Independent Director
Patrick J. Fortune PhD, MBA691996Independent Director
Richard L. Love722002Independent Director
Ellen M. Zane642006Independent Director
Christopher J. Lindop, CPA572006Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 52,900,000 52,171,877 98.6% 0 0.0% 98.6%
Shareholders
NameEquities%
BlackRock Fund Advisors 4,521,482 8.55%
The Vanguard Group, Inc. 4,249,354 8.03%
UBS Financial Services, Inc. 3,040,436 5.75%
Fisher Asset Management LLC 2,337,002 4.42%
SSgA Funds Management, Inc. 1,730,065 3.27%
Wellington Management Co. LLP 1,712,033 3.24%
Frontier Capital Management Co. LLC 1,455,420 2.75%
Neuberger Berman Investment Advisers LLC 1,395,406 2.64%
Fidelity Management & Research Co. 1,001,051 1.89%
Aberdeen Asset Managers Ltd. 998,811 1.89%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
PAREXEL INTERNATIONAL ..2.97%3 730
INCYTE CORPORATION-17.95%16 728
CELLTRION, INC.--.--%11 664
LONZA GROUP AG13.18%10 059
QUINTILES TRANSNATIONA..15.66%9 453
SEATTLE GENETICS, INC.24.40%7 845
ALKERMES PLC-37.54%7 514
ALNYLAM PHARMACEUTICAL..-19.73%6 478
QIAGEN NV-3.58%6 391
UNITED THERAPEUTICS CO..-18.77%5 530
IONIS PHARMACEUTICALS ..-43.29%4 247
ICON PLC-1.57%4 242
ACADIA PHARMACEUTICALS..-1.88%4 189
BIO-TECHNE CORP20.38%4 041
CHARLES RIVER LABORATO..2.95%3 914
PRA HEALTH SCIENCES IN..23.48%3 406
GALAPAGOS12.37%3 306
INTREXON CORP-9.09%3 243
BB BIOTECH AG-11.81%2 941
NEKTAR THERAPEUTICS11.28%2 564
INC RESEARCH HOLDINGS ..-7.37%2 467
Sector Biotechnology & Medical Research - NEC
PAREXEL International Corp : Connections
Applied Microarrays, Inc.
Harvard T.H. Chan School of Public Health
Agnovos Healthcare LLC
MedAptus, Inc.
Molecular Profiling Institute, Inc.
Tufts University
Jobs for Massachusetts, Inc.
New England Healthcare Institute
PHT Technologies, Inc.
Caris Molecular Profiling Institute, Inc.
TVP Management Co. LLC
The Leukemia & Lymphoma Society, Inc.
CardioMEMS, Inc.
Press Ganey Associates, Inc.
GlycoFi, Inc.
Association of Clinical Research Organizations
Epigenesis Pharmaceuticals LLC
MedTrust Online LLC
Sapphire Therapeutics, Inc.
Ascalon International, Inc.
University of Wisconsin Foundation
Syndevrx, Inc.
University of Illinois
PMed Management LLC
PAREXEL International Ltd.
Translational Accelerators LLC
The Floating Hospital, Inc.
Minuteman Health, Inc.
Cleveland Clinic
Sun Mountain Capital LLC
Cleveland Clinic Innovations
Century Capital Management, Inc.
CerRx, Inc.
George Washington University
Cancer Prevention Pharmaceuticals Inc
Global Med Technologies, Inc.
Company contact information
PAREXEL International Corp.
195 West Street
Waltham, MA 02451

Phone : +1.781.487.9900
Fax : +1.781.487.0525
Web : www.parexel.com
© 2016 People , Fundamentals and Ownership